Quantum-Mechanics and Machine Learning Drug Discovery.
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists.
The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research.
Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties (ADME, Tox, ...), obtaining insights of ligand / receptor interactions and identifying original backup compounds.
Learn more on how to de-risk your drug discovery project by emailing us at contact@pharmacelera.com or by visiting our webpage at www.pharmacelera.com
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists.
The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research.
Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties (ADME, Tox, ...), obtaining insights of ligand / receptor interactions and identifying original backup compounds.
Learn more on how to de-risk your drug discovery project by emailing us at contact@pharmacelera.com or by visiting our webpage at www.pharmacelera.com
Location: Spain
Employees: 11-50
Total raised: $8.1M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | The Collid... | thecollide... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.02.2026 | - | $7.02M | Inveready ... |
| 03.04.2020 | - | $1.08M | - |
Mentions in press and media 4
| Date | Title | Description |
| 18.02.2026 | Pharmacelera Raises €6 Million To Expand In U.S. And Advance Quantum-AI Platform | Pharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to drug discovery, announced it has closed a €6 million investment round to accelerate its expansion into the United States and further develop its pro... |
| 16.11.2018 | Next November 15 will take place the 23rd Forum of Investment in Healthcare | On November 15, the 23rd Healthcare Barcelona Investment Forum will be held at the CoMB headquarters, with the aim of putting in contact entrepreneurs and start-ups in the health sector with investors. Since its creation, in 2009, the Healt... |
| 28.07.2017 | How Barcelona’s Health Becomes Digital | Barcelona and Catalonia are renowned for its powerful life sciences research and the quality of the healthcare system. The country has produced world-leading scientists in the fields of cancer, HIV and other diseases. A powerful research ne... |
| - | Pharmacelera | “Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.” |